Times Square Investment Journal
  • Home
  • News
  • Company Insights
  • Stocks
  • Previews
  • Personal Finance
Select Page
Peloton’s strength offering can’t hold weight in a post-vaccine world

Peloton’s strength offering can’t hold weight in a post-vaccine world

by Jill Shah | Dec 17, 2020

  Ellie Moskova was doing Peloton’s cycling classes at the gym in her apartment building when she noticed the company added strength classes.  “I thought it would be a great addition to my schedule to have an instructor-led program,” said Moskova, a 26-year old...
Peloton’s blockbuster demand hits snag with shipping delays

Peloton’s blockbuster demand hits snag with shipping delays

by Jill Shah | Nov 6, 2020

  Peloton faces continued shipping delays for its products causing long wait times and poor customer service, despite strong growth in the first quarter of this year. The at-home connected fitness company said delays for its products will extend into the...
Peloton’s secret weapon: its fitness instructors and their social clout

Peloton’s secret weapon: its fitness instructors and their social clout

by Jill Shah | Nov 6, 2020

  As moats go, Peloton’s got a few: high-tech equipment refined over years, established supply chains and a native focus on virtual fitness. All of these were in place prior to the current pandemic-fueled explosion of connected fitness and at-home workouts....
Peloton’s blockbuster demand hits snag with shipping delays

Peloton’s stiffest competition yet: Equinox expands the SoulCycle bike nationally

by Jill Shah | Oct 17, 2020

  Peloton is facing new competition from Equinox as the luxury fitness company expands nationally in a bid for the growing at-home, connected fitness market.  Equinox announced on Wednesday that its stationary SoulCycle at-home bike would be available to...
Market tempers expectations for a clear winner in the vaccine race ahead of highly anticipated trial data

Market tempers expectations for a clear winner in the vaccine race ahead of highly anticipated trial data

by Jill Shah | Sep 28, 2020

Investors in COVID-19 vaccine companies who sent stocks soaring in the early months of the pandemic have lost confidence in the prospects of a clear winner. As the market awaits Phase II/Phase III trial data, analysts believe stocks could plunge in the coming weeks. ...

Investment Journal

Welcome to Investment Journal, a site covering the world of business right from Times Square. The site is produced by reporters at the New York City News Service and the Craig Newmark Graduate School of Journalism at CUNY. Email your comments to greg.david@journalism.cuny.edu.
  • Facebook
  • Twitter
  • Google
  • RSS

Designed by Elegant Themes | Powered by WordPress